Literature DB >> 8423909

Withdrawal of antiepileptic medication in children--effects on cognitive function: The Multicenter Holmfrid Study.

A P Aldenkamp1, W C Alpherts, G Blennow, D Elmqvist, J Heijbel, H L Nilsson, P Sandstedt, B Tonnby, L Wåhlander, E Wosse.   

Abstract

We present 100 children diagnosed with epilepsy who were seizure-free for more than 1 year and still on monotherapy of antiepileptic drugs (AEDs). We matched each child with a healthy classmate and performed neuropsychological testing and EEG before and after complete withdrawal of the AEDs. The withdrawal phase lasted 3 months, but the dose decrease was individualized for each patient. Three to 4 months after complete withdrawal of the drug all patients were reassessed. Patients with seizure relapse are excluded from the study. Seventeen patients are regarded as dropout, 11 because of seizure relapse and six because of protocol violation. The remaining 83 patients were treated with carbamazepine (n = 56), valproic acid (n = 17), or phenytoin (n = 10). Serum concentrations of the AEDs were measured using peak plasma levels that were taken immediately before or after psychological testing. We used neuropsychological tests to assess psychomotor function and "central" cognitive processing such as information processing or memory function. We found significant improvement attributable to drug withdrawal on only one of the cognitive tests, namely, psychomotor speed, suggesting that the impact of AED treatment on higher-order cognitive function is rather limited. In addition, we found group differences between the epilepsy group and the control group at baseline that persisted after drug withdrawal. Subsequent analysis showed some factors that may have contributed to these group differences. First, patients with a former diagnosis of absence seizures show lower scores both at baseline and after drug withdrawal. We may assume that the seizure propensity has not disappeared completely in these patients. Some evidence is found that phenytoin may have a different cognitive profile than carbamazepine, with more impairment on tests that measure motor and mental speed. Again, this impairment persists after drug withdrawal.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8423909     DOI: 10.1212/wnl.43.1_part_1.41

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  15 in total

Review 1.  Anticonvulsants and breast feeding: a critical review.

Authors:  B Bar-Oz; I Nulman; G Koren; S Ito
Journal:  Paediatr Drugs       Date:  2000 Mar-Apr       Impact factor: 3.022

2.  Cognition, academic achievement, language, and psychopathology in pediatric chronic epilepsy: Short-term outcomes.

Authors:  Jana E Jones; Prabha Siddarth; Suresh Gurbani; W Donald Shields; Rochelle Caplan
Journal:  Epilepsy Behav       Date:  2010-05-14       Impact factor: 2.937

Review 3.  Attention deficit and hyperactivity disorder, methylphenidate, and epilepsy.

Authors:  M Tan; R Appleton
Journal:  Arch Dis Child       Date:  2005-01       Impact factor: 3.791

4.  Development and validation of the Subjective Awareness of Neuropsychological Deficits Questionnaire for Children (SAND-C).

Authors:  Bradley J Hufford; Philip S Fastenau
Journal:  J Clin Exp Neuropsychol       Date:  2005-04       Impact factor: 2.475

5.  Cognitive slowing and its underlying neurobiology in temporal lobe epilepsy.

Authors:  Gyujoon Hwang; Kevin Dabbs; Lisa Conant; Veena A Nair; Jed Mathis; Dace N Almane; Andrew Nencka; Rasmus Birn; Colin Humphries; Manoj Raghavan; Edgar A DeYoe; Aaron F Struck; Rama Maganti; Jeffrey R Binder; Elizabeth Meyerand; Vivek Prabhakaran; Bruce Hermann
Journal:  Cortex       Date:  2019-03-05       Impact factor: 4.027

Review 6.  A comparative review of the adverse effects of anticonvulsants in children with epilepsy.

Authors:  S J Wallace
Journal:  Drug Saf       Date:  1996-12       Impact factor: 5.606

Review 7.  Neurocognitive Effects of Antiseizure Medications in Children and Adolescents with Epilepsy.

Authors:  Frank M C Besag; Michael J Vasey
Journal:  Paediatr Drugs       Date:  2021-05-06       Impact factor: 3.022

Review 8.  A practical guide to when (and how) to withdraw antiepileptic drugs in seizure-free patients.

Authors:  D Schmidt; L Gram
Journal:  Drugs       Date:  1996-12       Impact factor: 9.546

9.  Parents' Subjective Assessment of Effects of Antiepileptic Drug Discontinuation.

Authors:  Gun-Ha Kim; Jung Hye Byeon; So-Hee Eun; Baik-Lin Eun
Journal:  J Epilepsy Res       Date:  2015-06-30

10.  The impact of processing speed on cognition in temporal lobe epilepsy.

Authors:  Taylor M McMillan; Craig A Mason; Michael Seidenberg; Jana Jones; Bruce Hermann
Journal:  Epilepsy Behav       Date:  2021-07-15       Impact factor: 3.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.